SV

Shorya Veer Rana

Active Director Director DIN 10650556
DIN 10650556 First appointment May 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Shorya Veer Rana

Data last updated:

Shorya Veer Rana is a Director at Accordpharmacy Private Limited (since 2024). The company operates in Paper. Accordpharmacy Private Limited reported revenue of ₹5.1 Lakh (FY 2025).

DIN 10650556
Primary Designation Director
Industry Paper
First Appointment 31 May 2024
Oldest Company Age 2 yrs
Largest company Accordpharmacy Private Limited · ₹5.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Accordpharmacy Private Limited U21009UP2024PTC203764
Director31 May 20242024₹5.1 Lakh (FY 2025)Active

Board colleagues of Shorya Veer Rana

NameDINCompanyDesignation
Ravi Rana10650557Accordpharmacy Private LimitedDirector

Directorship timeline

Open interactive timeline →
Accordpharmacy Private Limited
Premium access

Shareholding and investment profile for Shorya Veer Rana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shorya Veer Rana

Shorya Veer Rana currently holds 1 directorship: Accordpharmacy Private Limited (Director, since 31 May 2024, revenue ₹5.1 Lakh (FY 2025)).

Shorya Veer Rana was first appointed on 31 May 2024 as Director at Accordpharmacy Private Limited.

The current boards of Shorya Veer Rana's companies include Ravi Rana (Accordpharmacy Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available